Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Franco, P. Reitsma, D. Lourenço, F. Maffei, V. Morelli, M. Tavella, Amelia Araujo, C. Piccinato, Marco Zago (1999)
Factor XIII Val34Leu Is a Genetic Factor Involved in the Aetiology of Venous ThrombosisThrombosis and Haemostasis, 81
H. Kohler, R. Ariëns, P. Whitaker, P. Grant (1998)
A Common Coding Polymorphism in the FXIII A-subunit Gene (FXIIIVAL34LEU) Affects Cross-linking ActivityThrombosis and Haemostasis, 80
M. Henry, P. Morange, I. Canavy, M. Alessi, I. Juhan-vague (1999)
Rapid Detection of Factor XIII Val34Leu by Allele Specific PCRThrombosis and Haemostasis, 81
U. Wartiovaara, M. Perola, H. Mikkola, K. Tötterman, V. Savolainen, Antti Penttilä, Peter Grant, Matti Tikkanen, Erkki Vartiainen, Pekka Karhunen, L. Peltonen, Aarno Palotie (1999)
Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males.Atherosclerosis, 142 2
H. Kohler, M. Stickland, N. Ossei-Gerning, A. Carter, H. Mikkola, P. Grant (1998)
Association of a Common Polymorphism in the Factor XIII Gene with Myocardial InfarctionThrombosis and Haemostasis, 79
Flávia Attié-Castro, M. Zago, J. Lavinha, J. Elion, L. Rodriguez-Delfin, J. Guerreiro, R. Franco (2000)
Ethnic Heterogeneity of the Factor XIII Val34Leu PolymorphismThrombosis and Haemostasis, 84
I. Balogh, G. Szőke, L. Kárpáti, U. Wartiovaara, É. Katona, I. Komáromi, G. Haramura, G. Pfliegler, H. Mikkola, L. Muszbek (2000)
Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.Blood, 96 7
H. Mikkola, Martti Syrjälä, Vesa Rasi, Elina Vahtera, E. Hämäläinen, Leena Peltonen, A. Palotie (1994)
Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels.Blood, 84 2
M. Hada, Marek Kaminski, P. Bockenstedt, J. Mcdonagh (1986)
Covalent crosslinking of von Willebrand factor to fibrin.Blood, 68 1
H. Kohler, M. Mansfield, P. Clark, P. Grant (1999)
Interaction between Insulin Resistance and Factor XIII Val34Leu in Patients with Coronary Artery DiseaseThrombosis and Haemostasis, 82
C. Greenberg, P. Birckbichler, R. Rice (1991)
Transglutaminases: multifunctional cross‐linking enzymes that stabilize tissuesThe FASEB Journal, 5
M. Margaglione, A. Bossone, V. Brancaccio, A. Ciampa, G. Minno (2000)
Factor XIII Val34Leu Polymorphism and Risk of Deep Vein ThrombosisThrombosis and Haemostasis, 84
Laszlo Lorand, A. Gray, K. Brown, R. Credo, C. Curtis, R. Domanik, P. Stenberg (1974)
Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen.Biochemical and biophysical research communications, 56 4
K. Suzuki, J. Henke, M. Iwata, L. Henke, H. Tsuji, T. Fukunaga, G. Ishimoto, M. Székelyi, S. Ito (1996)
Novel polymorphisms and haplotypes in the human coagulation factor XIII A-subunit geneHuman Genetics, 98
R. Franco, A. Pazin-Filho, MH Tavella, M. Simões, J. Marin-Neto, Marco Zago (2000)
Factor XIII val34leu and the risk of myocardial infarction.Haematologica, 85 1
M. Alhenc‐Gelas, J. Reny, M. Aubry, M. Aiach, J. Emmerich (2000)
The FXIII Val 34 Leu Mutation and the Risk of Venous ThrombosisThrombosis and Haemostasis, 84
H. Kohler, P. Grant (1998)
Clustering of Haemostatic Risk Factors with FXIIIVal34Leu in Patients with Myocardial InfarctionThrombosis and Haemostasis, 80
M. Schwartz, S. Pizzo, R. Hill, P. McKee (1973)
Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.The Journal of biological chemistry, 248 4
S. Kimura, N. Aoki (1986)
Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.The Journal of biological chemistry, 261 33
R. Ariëns, Hans Kohler, M. Mansfield, Peter Grant (1999)
Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension.Arteriosclerosis, thrombosis, and vascular biology, 19 8
T. Hornyak, P. Bishop, J. Shafer (1989)
Alpha-thrombin-catalyzed activation of human platelet factor XIII: relationship between proteolysis and factor XIIIa activity.Biochemistry, 28 18
Toni Trumbo, M. Maurer (2000)
Examining Thrombin Hydrolysis of the Factor XIII Activation Peptide Segment Leads to a Proposal for Explaining the Cardioprotective Effects Observed with the Factor XIII V34L Mutation*The Journal of Biological Chemistry, 275
H. Berg, G. Roosendaal, J. Voorberg, E. Mauser-Bunschoten (1999)
Inhibitor Development in a Multitransfused Patient with Severe Haemophilia AThrombosis and Haemostasis, 82
Hans Kohler, T. Futers, Peter Grant (1999)
FXII (46C→T) Polymorphism and In Vivo Generation of FXII ActivityThrombosis and Haemostasis, 81
S. Kangsadalampai, P. Board (1998)
The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity.Blood, 92 8
H. Mikkola, V. Yee, M. Syrjälä, R. Seitz, R. Egbring, P. Petrini, R. Ljung, J. Ingerslev, D. Teller, L. Peltonen, A. Palotie (1996)
Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit.Blood, 87 1
Hans Kohler, T. Futers, Peter Grant (1999)
Prevalence of Three Common Polymorphisms in the A-subunit Gene of Factor XIII in Patients with Coronary Artery DiseaseThrombosis and Haemostasis, 81
C. Curtis, K. Brown, R. Credo, R. Domanik, A. Gray, P. Stenberg, L. Lorand (1974)
Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor.Biochemistry, 13 18
A. Catto, H. Kohler, Sally Bannan, M. Stickland, A. Carter, P. Grant (1998)
Factor XIII Val 34 Leu: a novel association with primary intracerebral hemorrhage.Stroke, 29 4
L. Mccormack, K. Kain, A. Catto, H. Kohler, M. Stickland, P. Grant (1998)
Prevalence of FXIII V34L in Populations with Different Cardiovascular RiskThrombosis and Haemostasis, 80
R. Anwar, L. Gallivan, Stuart Edmonds, Alexander Markham (1999)
Genotype/phenotype correlations for coagulation factor XIII: specific normal polymorphisms are associated with high or low factor XIII specific activity.Blood, 93 3
R. Anwar, A. Stewart, K. Miloszewski, M. Losowsky, A. Markham (1995)
Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein functionBritish Journal of Haematology, 91
A. Ichinose, E. Davie (1988)
Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor.Proceedings of the National Academy of Sciences of the United States of America, 85 16
Y. Sakata, N. Aoki (1980)
Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.The Journal of clinical investigation, 65 2
A. Elbaz, O. Poirier, S. Canaple, F. Chédru, F. Cambien, P. Amarenco (2000)
The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction.Blood, 95 2
A. Catto, Hans Kohler, J. Coore, M. Mansfield, M. Stickland, P. Grant (1999)
Association of a Common Polymorphism in the Factor XIII Gene With Venous ThrombosisBlood, 93
R. Ariëns, H. Philippou, C. Nagaswami, J. Weisel, D. Lane, P. Grant (2000)
The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure.Blood, 96 3
M. Bale, L. Westrick, D. Mosher (1985)
Incorporation of thrombospondin into fibrin clots.The Journal of biological chemistry, 260 12
R. Procyk, B. Blombàck (1988)
Factor XIII-induced crosslinking in solutions of fibrinogen and fibronectin.Biochimica et biophysica acta, 967 2
Hämostaseologie Redaktion: C. M. Schambeck The Role of Factor XIII Val34Leu Polymorphism in Thrombotic Disease Die Rolle des Faktor XIII Val34Leu Polymorphismus bei thrombotischen Erkrankungen Silke Ehrenforth 1 , M. von Depka2 Summary: Activated blood coagulation factor (F) XIII (FXIIIa), a transglutaminase comprised of two A and two B subunits in a tetrameric structure (A2B2) of 320 kd, has a central role in the haemostatic system by cross-linking fibrin monomers in the final step of blood coagulation, thus stabilizing the fibrin clot and increasing its resistance to fibrinolysis. In addition, FXIIIa is implicated in the cross-linking of several other proteins, such as a-2-antiplasmin, fibronectin, and collagen. The impact of genetic variations of FXIII in thrombotic disorders has not been studied until recently, when a common polymorphism was described as a new candidate genetic factor influencing the risk of thrombotic diseases. This polymorphism results from a G to T transition in codon 34 of exon 2 of the catalytic FXIII A-subunit gene, leading to the substitution of leucine for valine (FXHIVal34Leu) close to the thrombin activation site. Genotype at this polymorphism is closely related to FXIII fibrin cross-linking activity, and FXIIILeu is associated with increased thrombin activation of FXIII
Laboratoriums Medizin / Journal of Laboratory Medicine – de Gruyter
Published: Jan 1, 2001
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.